series-b
Stage
2022
Founded
3
Investors
About
Cellular Intelligence develops computational and cell therapy platforms to design biological systems and advance next-generation cell therapies, including STEM-PD, a Phase 2-ready cell therapy for Parkinson's disease acquired from Novo Nordisk.
Explore Cellular Intelligence's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.